Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...
PHILADELPHIA (CBS) — A special clip that looks like a miniature clothespin is helping turn lives around. This is a treatment for people who have a heart valve problem that causes fatigue and ...
PARIS, France—Two studies presented at EuroPCR 2019 provide some reassurances that the newer-generation MitraClip XTR (Abbott), which features longer arms for grasping and increased maneuverability, ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. A study meant to serve as a ...
Hospitals that perform a larger number of transcatheter mitral valve repairs (TMVRs) with the MitraClip (Abbott) have significantly better procedural success, as well as shorter procedural times and ...
In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — “a Class I recall, the most serious type,” the FDA said. “Use of this device may cause serious injuries or death ...
On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...
A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, ...
A little device is about to make a big difference in millions of lives. Mitral regurgitation occurs when the valve that separates the main pumping chamber of the heart from the lungs is unable to ...
Failed transcatheter edge-to-edge repair of functional and degenerative mitral regurgitation (MR) with the MitraClip (Abbott) is relatively uncommon at high-volume centers but associated with a high ...
Abbott Laboratories, Inc. ABT recently presented late-breaking data from the Landmark COAPT trial for MitraClip, demonstrating the long-term benefits of the device in patients fighting heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback